chr19-37565194-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000451802.7(ZNF571):āc.1234A>Gā(p.Ile412Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000195 in 1,613,532 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000451802.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF571 | NM_016536.5 | c.1234A>G | p.Ile412Val | missense_variant | 4/4 | ENST00000451802.7 | NP_057620.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF571 | ENST00000451802.7 | c.1234A>G | p.Ile412Val | missense_variant | 4/4 | 1 | NM_016536.5 | ENSP00000392638.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000344 AC: 86AN: 249946Hom.: 0 AF XY: 0.000362 AC XY: 49AN XY: 135268
GnomAD4 exome AF: 0.000194 AC: 284AN: 1461384Hom.: 1 Cov.: 35 AF XY: 0.000197 AC XY: 143AN XY: 726950
GnomAD4 genome AF: 0.000204 AC: 31AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.1234A>G (p.I412V) alteration is located in exon 4 (coding exon 3) of the ZNF571 gene. This alteration results from a A to G substitution at nucleotide position 1234, causing the isoleucine (I) at amino acid position 412 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at